ISLET CELL ANTIBODY

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

AUTOIMMUNE.

Synonyms/Aliases

ISLET CELL CYTOPLASMIC ANTIBODY.

Abbreviations

ICA.

Type

INDIVIDUAL TEST.

14 DAYS

14 WORKING DAYS

Method

IMMUNOASSAY.

Temp

REFRIGERATED (2℃-8℃):7D; FROZEN (-20℃): 30D.

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

AT LEAST 2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

USEFUL FOR DIAGNOSING AUTOIMMUNE TYPE 1 DIABETES MELLITUS.

Test Limitations/ Confounders

N/A.

INTRINSIC FACTOR ANTIBODY

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

AUTOIMMUNE.

Synonyms/Aliases

ANTI-INTRINSIV FACTOR; INTRINSIC FACTOR BLOCKING ANTIBODY.

Abbreviations

IFAB.

Type

INDIVIDUAL TEST.

7 DAYS

7 WORKING DAYS.

Method

IMMUNOASSAY.

Temp

REFRIGERATED (2℃-8℃):7D, F (-20℃): 30D.

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

AT LEAST 2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

INTERPRETIVE DATA IS PROVIDED ON THE REPORT.

Clinical Utility

HIGHLY SPECIFIC FOR DIAGNOSIS OF PERNICIOUS ANAEMIA WHICH IS A CAUSE OF MEGALOBLASTIC ANEMIA.

Test Limitations/ Confounders

VITAMINS B12 ADMINISTRATION WITHIN THE PREVIOUS 1 WEEK CAN RESULT IN FALSE POSITIVE INTRINSIC FACTOR ANTIBODY RESULTS AND SHOULD BE AVOIDED. TEST IS POSITIVE ONLY IN 60% OF PATIENTS WITH PERNICIOUS ANEMIA.

HUMAN IMMUNODEFICIENCY VIRUS (HIV) RAPID TEST

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

INFECTIOUS.

Synonyms/Aliases

HIV SEROLOGY; HIV 1/2 SEROLOGY.

Abbreviations

HIV RDT.

Type

INDIVIDUAL TEST.

2 HRS

2 HOURS.

Method

IMMUNOCHROMATOGRAPHY.

Temp

AMBIENT (24 HOURS), REFRIGERATED (7 DAYS), FROZEN (14 DAYS).

Setup

ALL WORKING DAYS.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE (POSITIVE RESULTS ARE RECHECKED BY A DIFFERENT METHOD/ KIT IN LINE WITH NASCOP HTS ALGORITHM).

Clinical Utility

TESTS FOR PRESENCE OF HIV 1/ 2 ANTIBODIES AND P24 ANTIGEN.

Test Limitations/ Confounders

RESULTS ARE UNRELIABLE IN THE DIAGNOSIS OF HIV EXPOSED INFANTS AGED UP TO 18 MONTHS (HIV PROVIRAL DNA PCR ADVISED IN THIS AGE GROUP).

HUMAN IMMUNODEFICIENCY VIRUS (HIV) ELISA

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

INFECTIOUS.

Synonyms/Aliases

HIV p24 ANTIGEN/ ANTIBODY TEST, ELISA; HIV Ag/ Ab SEROLOGY; HIV 1/2 SEROLOGY.

Abbreviations

HIV ELISA, HIV DUO, HIV COMBO.

Type

INDIVIDUAL TEST.

5 DAYS

5 WORKING DAYS.

Method

AUTOMATED IMMUNOASSAY.

Temp

AMBIENT (24 HOURS), REFRIGERATED (7 DAYS), FROZEN (14 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE (POSITIVE RESULTS ARE RECHECKED BY A DIFFERENT METHOD/ KIT IN LINE WITH NASCOP HTS ALGORITHM).

Clinical Utility

A POSITIVE RESULT IS CONSISTENT WITH CURRENT/ RECENT HSV 2 INFECTION. IgM IS THE FIRST ANTIBODY PRODUCED BY THE IMMUNE SYSTEM IN RESPONSE TO INFECTION.

Test Limitations/ Confounders

N/A.

HERPES SIMPLEX VIRUS (HSV) 2, IgM

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

INFECTIOUS.

Synonyms/Aliases

HSV 2 IgM ANTIBODY.

Abbreviations

ANTI-HSV-2 IgM.

Type

INDIVIDUAL TEST.

5 DAYS

5 WORKING DAYS.

Method

AUTOMATED IMMUNOASSAY.

Temp

AMBIENT (24 HOURS), REFRIGERATED (7 DAYS), FROZEN (14 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY. SPECIFY EXACT ANTIBODY TYPE REQUIRED E.G. HSV 2 IgM RATHER THAN HSV 2 SEROLOGY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

A POSITIVE RESULT IS CONSISTENT WITH CURRENT/ RECENT HSV 2 INFECTION. IgM IS THE FIRST ANTIBODY PRODUCED BY THE IMMUNE SYSTEM IN RESPONSE TO INFECTION.

Test Limitations/ Confounders

N/A.

HERPES SIMPLEX VIRUS (HSV) 2, IgG

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

INFECTIOUS.

Synonyms/Aliases

HSV 2 IgG ANTIBODY.

Abbreviations

ANTI-HSV-2 IgG.

Type

INDIVIDUAL TEST.

5 DAYS

5 WORKING DAYS.

Method

AUTOMATED IMMUNOASSAY.

Temp

AMBIENT (24 HOURS), REFRIGERATED (7 DAYS), FROZEN (14 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY. SPECIFY EXACT ANTIBODY TYPE REQUIRED E.G. HSV 2 IgG RATHER THAN HSV 2 SEROLOGY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

IgG POSITIVITY IS CONSISTENT WITH PAST EXPOSURE TO HSV 2 INFECTION.

Test Limitations/ Confounders

N/A.

HERPES SIMPLEX VIRUS (HSV) 1, IgM

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

INFECTIOUS.

Synonyms/Aliases

HSV 1 IgM ANTIBODY.

Abbreviations

ANTI-HSV-1 IgM.

Type

INDIVIDUAL TEST.

5 DAYS

5 WORKING DAYS.

Method

AUTOMATED IMMUNOASSAY.

Temp

AMBIENT (24 HOURS), REFRIGERATED (7 DAYS), FROZEN (14 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY. SPECIFY EXACT ANTIBODY TYPE REQUIRED E.G. HSV 1 IgM RATHER THAN HSV 1 SEROLOGY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

A POSITIVE RESULT IS CONSISTENT WITH CURRENT/ RECENT HSV 1 INFECTION. IgM IS THE FIRST ANTIBODY PRODUCED BY THE IMMUNE SYSTEM IN RESPONSE TO INFECTION.

Test Limitations/ Confounders

N/A.

HERPES SIMPLEX VIRUS (HSV) 1, IgG

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

INFECTIOUS.

Synonyms/Aliases

HSV 1 IgG ANTIBODY.

Abbreviations

ANTI-HSV-1 IgG.

Type

INDIVIDUAL TEST.

5 DAYS

5 WORKING DAYS.

Method

AUTOMATED IMMUNOASSAY.

Temp

AMBIENT (24 HOURS), REFRIGERATED (7 DAYS), FROZEN (14 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY. SPECIFY EXACT ANTIBODY TYPE REQUIRED E.G. HSV 1 IgG RATHER THAN HSV 1 SEROLOGY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

IgG POSITIVITY IS CONSISTENT WITH PAST EXPOSURE TO HSV 1 INFECTION.

Test Limitations/ Confounders

N/A.

HEPATITIS E VIRUS (HEV), IgM

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

INFECTIOUS.

Synonyms/Aliases

ANTI-HEV, IgM; IgM ANTI-HEV.

Abbreviations

HEV IgM.

Type

INDIVIDUAL TEST.

5 DAYS

5 WORKING DAYS.

Method

IMMUNOASSAY.

Temp

AMBIENT (1 HOURS), REFRIGERATED (7 DAYS), FROZEN (30 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

A POSITIVE RESULT IS CONSISTENT WITH CURRENT/ RECENT HEPATITIS E VIRUS (HEV) INFECTION. IgM IS THE FIRST ANTIBODY PRODUCED BY THE IMMUNE SYSTEM IN RESPONSE TO INFECTION AND IS PRESENT DURING ACUTE OR CONVALESCENCE PHASE.

Test Limitations/ Confounders

N/A.

HEPATITIS E VIRUS (HEV), IgG

Category

SEROLOGY/ IMMUNOLOGY

Sub Category

INFECTIOUS.

Synonyms/Aliases

ANTI-HEV, IgG; IgG ANTI-HEV.

Abbreviations

HEV IgG.

Type

INDIVIDUAL TEST.

5 DAYS

5 WORKING DAYS.

Method

IMMUNOASSAY.

Temp

AMBIENT (24 HOURS), REFRIGERATED (7 DAYS), FROZEN (14 DAYS).

Setup

BATCHED.

Components Parameters

N/A

PRE-ANALYTIC CONSIDERATIONS

Test Ordering Instructions

FILL OUT TEST REQUEST FORM FULLY & LEGIBLY.

Patient preparation

N/A

Sample type

SERUM.

Container/ preservative

SERUM SEPARATOR TUBE (SST/ GEL) OR PLAIN (RED TOP) VACUTAINER.

Sample volume

2 ML.

Rejection criteria

LABELING ISSUE (UNLABELED/ MISLABELED); MISSING REQUEST FORM; MISMATCH BETWEEN REQUEST FORM & SAMPLE DETAILS; MISSING AGE/ GENDER; WRONG SAMPLE TYPE; INSUFFICIENT SAMPLE; HEMOLYZED, LIPEMIC, ICTERIC SAMPLES.

Other Instructions

CENTRIFUGE SST (SERUM GEL TUBES) WITHIN 1-2 HOURS OF COLLECTION. CENTRIFUGE RED TOP VACUTAINERS AND ALIQUOT SERUM WITHIN 1-2 HOURS OF COLLECTION. THE SEPARATION VIAL MUST BE LABELED WITH AT LEAST 2 PATIENT IDENTIFIERS AND THE SAMPLE TYPE.

Reference intervals

NEGATIVE.

Clinical Utility

IgG POSITIVITY IS CONSISTENT WITH IMMUNIZATION OR PAST EXPOSURE TO HEPATITIS E VIRUS (HEV).

Test Limitations/ Confounders

N/A.